In mouse models of ovarian and aggressive colon cancer, Tagworks Pharmaceuticals has demonstrated the potent antitumour effect of the company’s ‘click-to-release’ bioorthogonal chemistry approach. The results are published in the journal Nature Communications
Raffaella Rossin, et al., Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice, Nature Communications (2018), doi:10.1038/s41467-018-03880-y
Tagworks’ CEO Marc Robillard is one of the speakers at Antibody Engineering & Therapeutics Europe 2018 in Amsterdam from 5-7 June.
Marc will present the company’s latest results on “Click chemistry-triggered drug release from a tumor-bound ADC” on Thursday 7 June. His lecture is part of a session on “Novel antibody-based therapeutics for cancer and immuno-oncology”
More information on the event: https://lifesciences.knect365.com/antibody-engineering-europe/speakers
Tagworks CEO Marc Robillard talks about entrepreneurship in the life sciences field and shares his experiences as co-founder of Tagworks Pharmaceuticals during the InnoBoot Session: Business meets Science at the StartupDelta Summit on Thursday April 19, 2018, in Arnhem, the Netherlands.
More information on the event: https://startupdeltasummit.com/overdesummit/
Tagworks CSO Raffaella Rossin presents the company’s latest research achievements on ‘In vivo click chemistry’ at the 19th European Symposium on Radiopharmacy and Radiopharmaceuticals (ESRR) in Groningen, the Netherlands on Friday, April 6, 2018.
More information: http://www.esrr.info/welcome-address/
Tagworks CEO Marc Robillard will present at and co-chair the session on ‘Bioorthogonal and Click Chemistry for Molecular Imaging’ on Sunday October 21, 13:00-16:00, during the 30th Annual Conference of the European Association of Nuclear Medicine (EANM), October 21-25, 2017, Vienna, Austria.
More information on EANM’17: http://eanm17.eanm.org
Tagworks’ Research Manager Raffaella Rossin participates in the 22nd International Symposium on Radiopharmaceutical Sciences (iSRS) in Dresden, Germany, from May 14-19, 2017
More information on the conference: http://isrs2017.org
8-9 November 2017, 3rd Antibodies and Bio Therapeutics Congress, Las Vegas
10-11 January 2017, ‘Engineering for clinical success’: CHI’s 4th annual Antibody Drug Conjugates conference, San Diego
20-22 September 2017, 8th World ADC, San Diego